Roy A. Beveridge net worth and biography

Roy Beveridge Biography and Net Worth

Insider of Humana

Roy Beveridge, MD, a medical oncologist, provides insights and support across all Avalere practices, including the Center for Healthcare Transformation, Financial Services, and the Market Access team.

Roy most recently served as the chief medical officer of Humana, where he led clinical policy, population health, and clinical quality initiatives. He held similar roles at US Oncology and McKesson Specialty Health. His practical perspective on the dynamic between payers and providers as they engage around therapies and services is invaluable to our clients. His recent work has focused on social determinants of health and improving the health of underserved populations. He has published more than 200 papers.

Roy has a BA in biology from the Johns Hopkins University and an MD from Cornell University. He also received internal medicine training at the University of Chicago and did an oncology fellowship at Johns Hopkins.

What is Roy A. Beveridge's net worth?: The estimated net worth of Roy A. Beveridge is at least $3.85 million as of February 19th, 2019. Beveridge owns 12,409 shares of Humana stock worth more than $3,850,016 as of April 24th. This net worth estimate does not reflect any other assets that Beveridge may own. Learn More about Roy A. Beveridge's net worth.
How do I contact Roy A. Beveridge?: The corporate mailing address for Beveridge and other Humana executives is 500 West Main Street, LOUISVILLE KY, 40202. Humana can also be reached via phone at (502) 580-1000 and via email at [email protected]. Learn More on Roy A. Beveridge's contact information.
Has Roy A. Beveridge been buying or selling shares of Humana?: Roy A. Beveridge has not been actively trading shares of Humana within the last three months. Most recently, Roy A. Beveridge sold 8,278 shares of the business's stock in a transaction on Tuesday, February 19th. The shares were sold at an average price of $307.16, for a transaction totalling $2,542,670.48. Following the completion of the sale, the insider now directly owns 12,409 shares of the company's stock, valued at $3,811,548.44. Learn More on Roy A. Beveridge's trading history.
Who are Humana's active insiders?: Humana's insider roster includes Roy Beveridge (Insider), Jody Bilney (Insider), Bruce Broussard (CEO), M. Christopher (Insider), Samir Deshpande (Insider), Susan Diamond (CFO), William Fleming (CAO), Christopher Hunter (Insider), Timothy Huval (Insider), David Jones, Jr. (Director), Heidi Margulis (Insider), Jorge Mesquita (Director), James Murray (COO), Joseph Ventura (Insider), and Timothy Wheatley (Insider). Learn More on Humana's active insiders.
Are insiders buying or selling shares of Humana?: During the last twelve months, Humana insiders bought shares 1 times. They purchased a total of 545 shares worth more than $200,064.05. During the last twelve months, insiders at the insurance provider sold shares 1 times. They sold a total of 4,156 shares worth more than $2,187,219.68. The most recent insider tranaction occured on February, 20th when Director Jorge S Mesquita bought 545 shares worth more than $200,064.05. Insiders at Humana own 0.3% of the company. Learn More about insider trades at Humana.
Information on this page was last updated on 2/20/2024.

Roy A. Beveridge Insider Trading History at Humana

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/19/2019	Sell	8,278	$307.16	$2,542,670.48	12,409
11/8/2018	Sell	4,622	$341.06	$1,576,379.32	10,621
8/6/2018	Sell	14,306	$324.25	$4,638,720.50	15,274
2/22/2017	Sell	4,832	$205.73	$994,087.36	18,439

Roy A. Beveridge Buying and Selling Activity at Humana

Humana Company Overview

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Today's Range

Now: $310.26

$309.00

$336.40

50 Day Range

MA: $329.86

$304.33

$351.58

2 Week Range

Now: $310.26

$299.23

$541.21

Volume

1,869,471 shs

Average Volume

1,985,365 shs

Market Capitalization

$37.43 billion

P/E Ratio

15.65

Dividend Yield

1.09%

Beta

0.45

Global crypto currency reset (41 major banks signed up)

From Stansberry Research | Ad

Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...

Here's everything you need to know.